UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
Asian Currencies Stay Rangebound as Middle East Tensions, Weak China GDP Weigh on Sentiment 
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares 
Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030 
Asian Stocks Slide as Nikkei Leads Losses on Tech Selloff and Rising U.S.-Iran Tensions 
Oil Prices Set for Weekly Surge as U.S.-Iran Conflict Fuels Supply Fears 
Gold Prices Slip as Oil Rally Fuels Inflation Fears, Strengthens Dollar 
US Inflation Expected to Ease in June, but Fed Rate Hike Risks Persist Amid Middle East Tensions 
ECB's Kocher Says No Inflation Spillover Yet From Iran Conflict, Warns Risks Remain 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
Brazil Weighs IP Curbs, Patent Suspensions After New U.S. Tariffs 
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Asian Currencies Hold Steady as Middle East Tensions Offset Weaker US Dollar 
Gold Prices Head for Biggest Weekly Loss Since June as Fed Rate Outlook Weighs 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
